Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessShort communication

L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas

Laura Menendez1 email, Benedict B Benigno2 email and John F McDonald1,2 email

1Department of Genetics, University of Georgia, Life Science Building, Athens, GA 30602, USA

2The Ovarian Cancer Institute, 1100 Johnson Ferry Road, Suite 510, Atlanta, GA, 30342, USA

author email corresponding author email

Molecular Cancer 2004, 3:12doi:10.1186/1476-4598-3-12

Published: 26 April 2004

Abstract

Wide-spread hypomethylation of CpG dinucleotides is characteristic of many cancers. Retrotransposons have been identified as potential targets of hypomethylation during cellular transformation. We report the results of an preliminary examination of the methylation status of CpG dinucleotides associated with the L1 and HERV-W retrotransposons in benign and malignant human ovarian tumors. We find a reduction in the methylation of CpG dinucleotides within the promoter regions of these retroelements in malignant relative to non-malignant ovarian tissues. Consistent with these results, we find that relative L1 and HERV-W expression levels are elevated in representative samples of malignant vs. non-malignant ovarian tissues.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.